Canonical Wnt signaling is known to be active in HSC [31] and in AML expressing specific oncogenes such as MLL-AF9, AML1-ETO and PML-RARα [17, 28, 29]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.